2013
DOI: 10.1053/j.jepm.2013.08.007
|View full text |Cite
|
Sign up to set email alerts
|

Multidrug-Resistant Pseudomonas aeruginosa Isolates From Captive Reptiles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
12
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 8 publications
1
12
1
Order By: Relevance
“…Therefore, P. aeruginosa can be considered part of the gut microbiota of healthy ophidians. However, the overall P. aeruginosa prevalence found here (59.9%) was lower than expected based on other studies performed on captive snakes (Colinon et al, 2010; Foti et al, 2013; Dipineto et al, 2014). Eighty-nine (35.5%) of the P. aeruginosa isolates were MDR.…”
Section: Discussioncontrasting
confidence: 87%
“…Therefore, P. aeruginosa can be considered part of the gut microbiota of healthy ophidians. However, the overall P. aeruginosa prevalence found here (59.9%) was lower than expected based on other studies performed on captive snakes (Colinon et al, 2010; Foti et al, 2013; Dipineto et al, 2014). Eighty-nine (35.5%) of the P. aeruginosa isolates were MDR.…”
Section: Discussioncontrasting
confidence: 87%
“…P. aeruginosa were susceptible to ciprofloxacin in 10 of 16 (62·5%) cases, which is comparable to the findings of a study from Japan, where 77% of all P. aeruginosa isolates from chinchillas were susceptible to ciprofloxacin (Hirakawa et al 2010 ). Ciprofloxacin is generally considered as the more potent fluoroquinolone against P. aeruginosa compared to enrofloxacin or marbofloxacin (Oliveira et al 2007, Wildermuth et al 2007, Foti et al 2013. Currently no pharmacokinetic studies in chinchillas on any fluoroquinolone antibiotic are available and therefore choosing dose and frequency relies on extrapolation from studies in other species.…”
Section: Discussionsupporting
confidence: 81%
“…, Foti et al . ). Currently no pharmacokinetic studies in chinchillas on any fluoroquinolone antibiotic are available and therefore choosing dose and frequency relies on extrapolation from studies in other species.…”
Section: Discussionmentioning
confidence: 99%
“…This way, veterinarians often deal with these diseases in reptiles empirically, using a wide range of antibiotics [4]. This practice might result in the development of resistant bacterial stumps [5], what stands out due to the potential that resistant bacteria have to generate infections and zoonoses in humans [1].…”
Section: Discussionmentioning
confidence: 99%
“…Among the bacterial diseases in serpents, the ones caused by gram-negative agents stand out, which, in most cases, are resistant to medicines of a broad spectrum most commonly used in the clinical routine of wild animals [4]. This way, veterinarians often deal with these diseases in reptiles empirically, using a wide range of antibiotics, what can lead to the development of resistant stumps in the bacteria [5].…”
Section: Introductionmentioning
confidence: 99%